HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gottlieb Leaves FDA With Final Thought On What To Do About Cosmetics

Executive Summary

Addressing for the last time the House Appropriations subcommittee with FDA oversight, Commissioner Scott Gottlieb shared his vision for sharpening cosmetics oversight in the absence of significant new resources.

Advertisement

Related Content

ICMAD: Federal Cosmetics Legislation Without National Uniformity Not In Industry’s Interest
Gottlieb's Parting Words For US FDA: 'Be Willing To Push' For Major Policy Changes
Gottlieb Unleashed: Focus on Drug Pricing To Intensify As He Rejoins AEI
Departing FDA Head Gottlieb Advises Successor Sharpless To Heed Center Directors, Defends Budget To Congress
Cosmetics ‘Are Not Risk-Free’; FDA Committed to Modernizing Regs – Commish Gottlieb

Topics

Advertisement
UsernamePublicRestriction

Register

RS148717

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel